# INO (Inovio Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Inovio Pharmaceuticals, Inc. reported $299K in revenue and a net loss of $71.14M for the trailing twelve months ended September 30, 2026 (down 70.0% year over year), with a -25953.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/INO
- Markdown: https://convexityos.com/fundamentals/INO.md
- SEC CIK: 0001055726
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001055726&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $299K | -70.0% YoY |
| Operating Income | TTM | -$77.58M | -25953.8% margin |
| Net Income | TTM | -$71.14M | -23798.9% net margin |
| Diluted EPS | TTM | -$0.72 | Split-adjusted |
| Free Cash Flow | TTM | -$74.41M | -24894.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $48.36M | Total debt: $7.28M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $65K | $218K | $832K | $10.26M | $1.77M | $7.41M | $4.11M | $30.48M | $42.22M | $35.37M |
| Research & Development | $54.21M | $75.62M | $86.68M | $187.7M | $249.2M | $94.25M | $88.02M | $95.26M | $98.57M | $88.71M |
| Total Operating Expenses | $86.89M | $112.6M | $144.8M | $277.8M | $303.0M | $131.5M | $115.2M | $124.6M | $125.9M | $111.6M |
| **Operating Income** | -$86.82M | -$112.4M | -$143.9M | -$267.6M | -$301.2M | -$124.1M | -$111.1M | -$94.09M | -$83.64M | -$76.24M |
| **EBITDA** | -$85.40M | -$110.6M | -$141.2M | -$263.4M | -$297.7M | -$120.5M | -$106.4M | -$89.09M | -$80.17M | -$73.15M |
| Interest Income | $2.42M | $4.77M | $8.13M | $4.78M | $3.36M | $3.31M | $2.61M | $2.26M | $1.84M | -- |
| Interest Expense | $0 | $178K | $1.22M | $1.25M | $1.94M | $8.70M | $7.95M | $0 | $26K | -- |
| Income Before Tax | -$84.95M | -$107.3M | -$135.1M | -$277.7M | -$303.2M | -$162.9M | -$120.8M | -$94.80M | -$88.21M | -$73.74M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$257K | $2.17M | $0 | $0 |
| **Net Income** | -$84.95M | -$107.3M | -$135.1M | -$279.8M | -$303.7M | -$166.4M | -$119.4M | -$96.97M | -$88.21M | -$73.74M |
| Basic EPS | -$1.81 | -$3.95 | -$6.09 | -$14.07 | -$17.45 | -$12.85 | -$14.53 | -$12.61 | -$12.97 | -$12.12 |
| **Diluted EPS** | -$1.81 | -$3.95 | -$6.09 | -$14.07 | -$17.45 | -$12.85 | -$14.53 | -$12.61 | -$13.09 | -$12.12 |
| Basic Shares Outstanding | 46.9M | 27.2M | 22.2M | 19.9M | 17.4M | 12.9M | 8.2M | 7.7M | 6.8M | 6.1M |
| Diluted Shares Outstanding | 46.9M | 27.2M | 22.2M | 19.9M | 17.4M | 12.9M | 8.2M | 7.7M | 6.8M | 6.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $299K | $0 | $0 | $0 | $0 | $0 | $65K | $117K |
| Research & Development | $10.62M | $10.83M | $14.07M | $10.26M | $13.33M | $14.52M | $16.09M | $12.89M |
| Total Operating Expenses | $19.82M | $18.62M | $21.95M | $17.48M | $21.21M | $23.08M | $25.12M | $20.49M |
| **Operating Income** | -$19.52M | -$18.62M | -$21.95M | -$17.48M | -$21.21M | -$23.08M | -$25.05M | -$20.37M |
| **EBITDA** | -$19.20M | -$18.30M | -$21.63M | -$17.14M | -$20.86M | -$22.73M | -$24.68M | -$19.95M |
| Interest Income | $356K | $364K | $440K | $449K | $552K | $611K | $808K | $853K |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$49.20M | -$6.01M | -$19.68M | $3.76M | -$45.50M | -$23.52M | -$19.69M | -$19.38M |
| Basic EPS | -$0.50 | -$0.07 | -$0.28 | -- | -$0.87 | -$0.61 | -$0.51 | -- |
| **Diluted EPS** | -$0.50 | -$0.07 | -$0.28 | -- | -$0.87 | -$0.61 | -$0.51 | -- |
| Basic Shares Outstanding | 98.6M | 81.6M | 69.1M | -- | 52.2M | 38.8M | 38.6M | -- |
| Diluted Shares Outstanding | 98.6M | 81.6M | 69.1M | -- | 52.2M | 38.8M | 38.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $44.27M | $65.81M | $14.31M | $46.33M | $71.14M | $250.7M | $22.20M | $23.69M | $23.79M | $19.14M |
| Short-Term Investments | $14.24M | $28.30M | $131.0M | $206.7M | $330.2M | $160.9M | $67.34M | $57.54M | $103.6M | $85.63M |
| **Cash & Short-Term Investments** | $58.50M | $94.10M | $145.3M | $253.0M | $401.3M | $411.6M | $89.50M | $81.20M | $127.4M | $104.8M |
| Accounts Receivable, Net | $450 | $1.20M | $2.41M | $1.70M | $5.47M | $18.56M | $700K | $3.32M | $6.00M | $15.82M |
| **Total Current Assets** | $61.12M | $97.83M | $153.1M | $315.2M | $448.4M | $471.2M | $94.20M | $87.81M | $138.4M | $124.6M |
| Property, Plant & Equipment, Net | $2.53M | $3.66M | $4.96M | $7.73M | $17.45M | $11.35M | $12.77M | $15.95M | $18.32M | $9.03M |
| Goodwill | -- | -- | $0 | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M | $10.51M |
| Intangible Assets | -- | -- | $0 | $2.13M | $2.63M | $3.15M | $3.69M | $4.76M | $6.01M | $7.63M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $9.40M | -- | -- |
| Other Non-Current Assets | $2.01M | $1.98M | $605K | $684K | $1.43M | $25.96M | $2.67M | $2.67M | $2.64M | $2.11M |
| **Total Non-Current Assets** | $13.19M | $15.37M | $17.84M | $33.29M | $47.50M | $68.60M | $49.75M | $43.30M | $48.88M | $49.11M |
| **Total Assets** | $74.31M | $113.2M | $171.0M | $348.5M | $495.9M | $539.8M | $144.0M | $131.1M | $187.2M | $173.7M |
| Deferred Revenue (Current) | $0 | -- | -- | $0 | $22K | $47K | $92K | $224K | $1.18M | $14.76M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | $0 | -- |
| **Total Current Liabilities** | $43.67M | $35.33M | $42.57M | $96.87M | $65.74M | $41.71M | $31.99M | $35.30M | $35.41M | $43.82M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $64K | $79K | $102K | $151K | $216K | $318K |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $15K | $58K | $37K | $87K | $0 | -- |
| **Total Non-Current Liabilities** | $6.55M | $9.37M | $11.03M | $29.30M | $30.53M | $36.93M | $106.6M | $8.78M | $9.35M | $6.51M |
| **Total Liabilities** | $50.21M | $44.69M | $53.60M | $126.2M | $96.27M | $78.63M | $138.5M | $44.08M | $44.75M | $50.33M |
| **Total Debt (incl. Leases)** | $9.37M | $11.87M | $13.44M | $15.46M | $18.06M | $20.39M | $22.48M | $0 | -- | -- |
| Common Stock | $69K | $36K | $23K | $21K | $217K | $187K | $101K | $97K | $90K | $74K |
| Retained Earnings | -$1.82B | -$1.73B | -$1.62B | -$1.49B | -$1.21B | -$906.2M | -$739.8M | -$620.4M | -$523.4M | -$434.8M |
| Accumulated Other Comp. Income | -$638K | -$676K | -$663K | -$699K | -$282K | -$256K | $473K | -$529K | -$117K | $1.33M |
| **Total Stockholders' Equity** | $24.10M | $68.50M | $117.3M | $222.4M | $399.7M | $461.1M | $3.44M | $86.94M | $142.4M | $123.3M |
| Total Equity | $24.10M | $68.50M | $117.3M | $222.4M | $399.7M | $461.1M | $5.40M | $87.03M | $142.5M | $123.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $46.96M | $31.53M | $26.27M | $44.27M | $36.57M | $24.35M | $39.92M | $65.81M |
| Short-Term Investments | $1.40M | $5.15M | $11.41M | $14.24M | $14.24M | $23.20M | $28.45M | $28.30M |
| **Cash & Short-Term Investments** | $48.40M | $36.70M | $37.70M | $58.50M | $50.80M | $47.50M | $68.40M | $94.10M |
| Accounts Receivable, Net | -- | -- | -- | $450 | $979K | $840K | $1.31M | $1.20M |
| **Total Current Assets** | $51.44M | $39.91M | $39.44M | $61.12M | $55.18M | $52.70M | $71.89M | $97.83M |
| Property, Plant & Equipment, Net | $1.57M | $1.89M | $2.21M | $2.53M | $2.74M | $3.09M | $3.35M | $3.66M |
| Other Non-Current Assets | $1.92M | $1.92M | $2.01M | $2.01M | $2.01M | $2.01M | $1.98M | $1.98M |
| **Total Non-Current Assets** | $8.69M | $9.48M | $10.34M | $13.19M | $14.21M | $15.54M | $15.38M | $15.37M |
| **Total Assets** | $60.14M | $49.39M | $49.78M | $74.31M | $69.39M | $68.24M | $87.27M | $113.2M |
| Deferred Revenue (Current) | $652K | -- | -- | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $89.47M | $39.92M | $37.92M | $43.67M | $69.82M | $31.71M | $27.33M | $35.33M |
| **Total Non-Current Liabilities** | $4.59M | $5.10M | $5.79M | $6.55M | $7.28M | $8.00M | $8.70M | $9.37M |
| **Total Liabilities** | $94.06M | $45.02M | $43.71M | $50.21M | $77.11M | $39.71M | $36.02M | $44.69M |
| **Total Debt (incl. Leases)** | $7.28M | $8.00M | $8.70M | $9.37M | $10.02M | $10.66M | $11.27M | $11.87M |
| Common Stock | $110K | $82K | $70K | $69K | $54K | $37K | $37K | $36K |
| Retained Earnings | -$1.89B | -$1.84B | -$1.83B | -$1.82B | -$1.82B | -$1.77B | -$1.75B | -$1.73B |
| Accumulated Other Comp. Income | -$267K | -$280K | -$636K | -$638K | -$647K | -$662K | -$661K | -$676K |
| **Total Stockholders' Equity** | -$33.92M | $4.37M | $6.07M | $24.10M | -$7.72M | $28.53M | $51.25M | $68.50M |
| Total Equity | -$33.92M | $4.37M | $6.07M | $24.10M | -$7.72M | $28.53M | $51.25M | $68.50M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$84.95M | -$107.3M | -$135.1M | -$279.8M | -$303.7M | -$167.5M | -$120.6M | -$96.97M | -$88.21M | -$73.74M |
| Depreciation & Amortization | $1.42M | $1.75M | $2.77M | $4.15M | $3.56M | $3.59M | $4.66M | $5.00M | $3.47M | $3.09M |
| Stock-Based Compensation | $3.76M | $6.60M | $11.07M | $22.56M | $26.34M | $15.65M | $10.90M | $10.65M | $13.07M | $10.48M |
| Change in Receivables | -- | $1.21M | $9.33M | -$3.71M | $11.03M | -$17.02M | $2.62M | $2.69M | $9.82M | -$8.52M |
| **Operating Cash Flow** | -$88.63M | -$104.1M | -$124.4M | -$216.2M | -$215.7M | -$178.0M | -$97.85M | -$73.55M | -$63.21M | -$62.56M |
| Capital Expenditure | -$286K | -$488K | -$321K | -$969K | -$1.23M | -$1.52M | -$988K | -$2.09M | -$10.29M | -$2.74M |
| **Free Cash Flow** | -$88.92M | -$104.6M | -$124.7M | -$217.2M | -$216.9M | -$179.5M | -$98.84M | -$75.64M | -$73.50M | -$65.29M |
| **Investing Cash Flow** | $14.04M | $104.1M | $87.36M | $109.6M | -$175.3M | -$58.80M | -$9.04M | $42.42M | -$27.83M | $16.27M |
| Common Stock Issued | $34.91M | $36.03M | $5.46M | $82.96M | $209.4M | $454.5M | $9.09M | $29.23M | $94.35M | $6.30M |
| **Financing Cash Flow** | $53.05M | $51.48M | $5.00M | $81.84M | $211.5M | $465.3M | $105.4M | $31.04M | $95.69M | $7.79M |
| **Net Change in Cash** | -$21.54M | $51.50M | -$32.02M | -$24.81M | -$179.6M | $228.5M | -$1.50M | -$93K | $4.65M | -$38.50M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$49.20M | -$6.01M | -$19.68M | $3.76M | -$45.50M | -$23.52M | -$19.69M | -$19.38M |
| Depreciation & Amortization | $322K | $322K | $317K | $340K | $350K | $356K | $371K | $417K |
| Stock-Based Compensation | $868K | $768K | $699K | $765K | $757K | $835K | $1.40M | $1.32M |
| Change in Receivables | -- | -- | -- | -- | -$138K | $470K | -$111K | $664K |
| **Operating Cash Flow** | -$15.27M | -$18.05M | -$21.59M | -$19.37M | -$21.57M | -$20.81M | -$26.87M | -$19.66M |
| Capital Expenditure | $0 | $0 | $0 | -$127K | -$68K | -$31K | -$59K | $0 |
| **Free Cash Flow** | -$15.27M | -$18.05M | -$21.59M | -$19.50M | -$21.64M | -$20.84M | -$26.93M | -$19.66M |
| **Investing Cash Flow** | $3.72M | $6.15M | $2.64M | -$58K | $8.87M | $5.28M | -$52K | $34.64M |
| Common Stock Issued | $3.01M | $3.25M | $1.08M | $26.62M | $7.19M | $0 | $1.10M | $13.08M |
| **Financing Cash Flow** | $26.99M | $17.16M | $954K | $27.13M | $24.92M | -$35K | $1.03M | $29.15M |
| **Net Change in Cash** | $15.44M | $5.25M | -$18.00M | $7.71M | $12.22M | -$15.56M | -$25.90M | $44.13M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -132871.3% | -51616.9% | -17300.3% | -2607.4% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.5% |
| **Net Profit Margin** | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% | -2245.4% | -2902.8% | -318.1% | -208.9% | -208.5% |
| Return on Equity (ROE) | -352.5% | -156.6% | -115.1% | -125.8% | -76.0% | -36.1% | -3474.7% | -111.5% | -61.9% | -59.8% |
| Return on Assets (ROA) | -114.3% | -94.7% | -79.0% | -80.3% | -61.2% | -30.8% | -82.9% | -74.0% | -47.1% | -42.5% |
| Current Ratio | 1.40x | 2.77x | 3.60x | 3.25x | 6.82x | 11.30x | 2.94x | 2.49x | 3.91x | 2.84x |
| Quick Ratio | 1.34x | 2.70x | 3.47x | 2.63x | 6.19x | 10.31x | 2.82x | 2.39x | 3.77x | 2.75x |
| Debt to Equity | 0.39x | 0.17x | 0.11x | 0.07x | 0.05x | 0.04x | 6.55x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -70.0% | -73.8% | -91.9% | +478.2% | -76.1% | +80.2% | -86.5% | -27.8% | +19.4% | -12.8% |
| 5Y Revenue / Share Growth | -99.8% | -98.4% | -99.1% | -91.7% | -98.2% | -92.0% | -76.4% | +12.7% | +327.8% | +55.6% |
| 10Y Revenue / Share Growth | -100.0% | -99.6% | -98.9% | -64.4% | -97.3% | -79.9% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -25953.8% | -- | -- | -132871.3% | -49202.9% | -52568.6% | -37430.2% | -51616.9% |
| **Net Profit Margin** | -23798.9% | -- | -- | -130000.0% | -59281.7% | -48131.4% | -34079.6% | -49254.3% |
| Return on Equity (ROE) | -- | -1542.6% | -1399.7% | -352.5% | -- | -307.6% | -188.2% | -156.6% |
| Return on Assets (ROA) | -118.3% | -136.5% | -170.6% | -114.3% | -155.8% | -128.6% | -110.5% | -94.7% |
| Current Ratio | 0.57x | 1.00x | 1.04x | 1.40x | 0.79x | 1.66x | 2.63x | 2.77x |
| Quick Ratio | 0.54x | 0.92x | 0.99x | 1.34x | 0.74x | 1.52x | 2.55x | 2.70x |
| Debt to Equity | -- | 1.83x | 1.43x | 0.39x | -- | 0.37x | 0.22x | 0.17x |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -100.0% | -- | -100.0% | -- | +14.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
